Comments on ''Geranylgeraniol--a new potential therapeutic approach to bisphosphonate associated osteonecrosis of the jaw" by Ziebart T et al. (2011)

Oral Oncol. 2011 May;47(5):436-7; author reply 438. doi: 10.1016/j.oraloncology.2011.02.017. Epub 2011 Mar 15.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Bone Density Conservation Agents / adverse effects
  • Diphosphonates / adverse effects*
  • Diterpenes / therapeutic use*
  • Humans
  • Jaw Diseases / chemically induced
  • Jaw Diseases / drug therapy*
  • Osteonecrosis / chemically induced
  • Osteonecrosis / drug therapy*

Substances

  • Bone Density Conservation Agents
  • Diphosphonates
  • Diterpenes
  • geranylgeraniol